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酰胺的直接转化: 仲酰胺与丹尼谢夫斯基双烯的还原环加成反应 
郑剑峰*    谢志强    陈欣健    黄培强* 
(福建省化学生物学重点实验室  厦门大学化学化工学院化学生物学系  厦门 361005) 
摘要  酰胺作为稳定的合成中间体被广泛应用于有机合成和药物化学. 因此, 发展通用、化学选择性的酰胺直接转化
的方法十分重要. 在本工作中, 我们报道仲酰胺与丹尼谢夫斯基双烯的还原环加成反应, 用于把仲酰胺直接转化为 2-
取代-2,3-二氢-4-吡啶酮. 该“一瓶反应”包含酰胺通过三氟甲磺酸酐活化、部分还原、和[4＋2]环加成反应 3 个环节. 基
于这一步骤经济型方法, 建立了生物碱(±)-lasubine I 和(±)-myrtine 的简便、无保护基全合成. 
关键词  酰胺; 一瓶反应; 环加成反应; 活化; 三氟甲磺酸酐; 生物碱 
 
Direct Transformation of Amides: Reductive Cycloaddition of Secondary  
Amides with Danishefsky Diene 
Jian-Feng Zheng*    Zhi-Qiang Xie    Xin-Jian Chen    Pei-Qiang Huang* 
(Fujian Provincial Key Laboratory of Chemical Biology, Department of Chemical Biology, College of Chemistry and Chem-
ical Engineering, Xiamen University, Xiamen 361005) 
Abstract  Amides are widely used as stable synthetic intermediates in organic synthesis and medicinal chemistry. 
Versatile and chemoselective C—C bond forming methods for the direct transformation of amides are highly demand-
ing. In this paper, we report the reductive cycloaddition of common secondary amides with the Danishefsky diene to 
produce 2-substituted 2,3-dihydro-4-pyridones. This one-pot procedure involves amide activation with triflic anhy-
dride, partial reduction, and [4＋2] cycloaddition. The synthetic utility of this step-econimical method was demon-
strated by the short and protecting-group-free total syntheses of alkaloids (±)-lasubine I and (±)-myrtine. 
Keywords  amides; one-pot reaction; cycloaddition reaction; activation; triflic anhydride; alkaloids 
   
1  Introduction 
Amides are commonly used as advantageous synthetic 
intermediates in organic synthesis and medicinal chemistry 
because of their high stability.[1,2] When employed as syn-
thetic intermediates, the amide group needs to be converted 
into other needed functional group at a latter stage of a 
synthetic sequence. In recent years, significant progress 
has been made in the one-pot transformation of amides into 
other classes of compounds via C—C bond formation reac-
tions.[3] Notable examples include the reductive cyanation 
of secondary amides,[4] the Vilsmeier-Haack-type cycliza-
tions/reactions,[5] the reductive bisalkylation of tertiary 
amides,[6] the reductive cyclization of secondary amide,[1h,1l] 
reductive alkylation/functionalization of secondary[7] and 
tertiary[8] amides, reductive alkylation/functionalization of 
N-alkoxylamides,[9,3b] deaminative alkylation of secondary 
amides,[10] the amide-based Claisen rearrangement,[11] the 
nitro-Mannich reaction,[12] tertiary amides-based 
knoevenagel-type reactions,[13] and reductive coupling of 
secondary amides.[14] 
The [4＋2] cycloaddition using an imine as the dieno-
phile has been known for over seventy years.[15] The semi-
nal work of Danishefsky has paved the Lewis ac-
id-promoted [4＋2] aza-cycloaddition of imines 1 with 
electon-riched silyloxydienes such as 1-methoxy-3- trime-
thylsilyloxy-1,3-butadiene (the Danishefsky diene 2, 
Scheme 1).[16] This reaction has become a powerful tool for 
the construction of 2,3-dihydro-4-pyridone derivatives 












Scheme 1  The Lewis acid-promoted aza-cycloaddition of Danishefsky 
diene with aldimines 
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containing alkaloids has been demonstrated.[18]  
Although significant progress has been achieved re- 
cently on novel C—C bond forming reactions from       
amides,[3～14] to the best of our knowledge there is no report 
on the use of common secondary amides for the one-pot  
synthesis of 2-substituted 2,3-dihydro-4-pyridones. As part 
of our program to develop efficient methods for the syn-
thesis of N-containing molecules,[19] we have been inter-
ested in developing C—C bond forming reactions starting 
from common amides [7e,7f,8b～8d,8f,10b,10c,13,14] based on the in 
situ amide activation with triflic anhydride (Tf2O).
[20] Con-
tinuing the effort, we report herein the one-pot reductive 
cycloaddition of secondary amides 4[21] with the Danishef-
sky diene 2 for the synthesis of 2,3-dihydro-4-pyridones 
and its application in the total syntheses of quinolizidine 
alkaloids (±)-lasubine I (5) and (±)-myrtine (6). 
We reported recently that the iminium ion A generated 
in situ from a secondary amide 4 by successive treatment 
with Tf2O/2-F-Py (2-fluoropyridine) and triethylsilane
[22] 
can participate in several C—C bond forming reactions to 
afford functionalized amines B,[7f] vicinal diamines C,[14] 
or β-amino alcohols D[14] (Scheme 2). We envisioned that 
under appropriate conditions, the imines 1 may also be 
captured by the Danishefsky diene 2 to give 





















































Scheme 2  C—C Bond forming reactions of the iminium ions generated 
in situ from secondary amides 
2  Results and Discussion 
N-Butylbenzamide 4a was chosen as the model substrate 
for our investigation. Thus 4a was treated sequentially with 
Tf2O (1.1 equiv.) and 2-F-Py (1.2 equiv.) at 0 ℃ for 30 
min, Et3SiH at 0 ℃ to r.t. for 5 h, the Danishefsky diene, 
triethylamine (2 equiv.) and a Lewis acid (1.5 equiv.) at r.t. 
for 6 h (Table 1). To our delight, the use of Lewis acids like 
ZnCl2, BF3•Et2O, TMSOTf and TiCl4, did lead to the for-
mation of the desired product 3a in 59%, 39%, 35% and 
22% yield, respectively (Table 1, Entries 1～4). In 2002, 
Ding reported that the aza-Diels-Alder reaction benefits 
from the use of polar solvents.[17f] Inspired by this work, 
we screened different solvents for the cycloaddition step 
and were pleased to find that the yield was improved to 
80% in MeOH.[17f] Other solvents such as THF and MeCN 
were less effective. In comparison, the use of non-polar 
solvents such as diethyl ether and toluene led to only trace 
or no desired adduct (Table 1, Entries 7 and 8). Thus, the 
optimal conditions for the one-pot reduction of secondary 
amides and tandem cycloaddition of the resulting imines 
with the Danishefsky diene 2 were defined as those shown 
in Table 2. Note that the use of triethylamine as an addi-
tive[14] is critical for the success of the reaction. 











Tf2O, 2-F-Py, CH2Cl2, 0 
oC
Et3SiH, r.t., 5 h




Entry Lewis acid Solvent Yielda/% 
1 BF3-OEt2 CH2Cl2 39 
2 TMSOTf CH2Cl2 35 
3 TiCl4 CH2Cl2 22 
4 ZnCl2 CH2Cl2 59 
5 ZnCl2 THF 74 
6 ZnCl2 CH3CN 78 
7 ZnCl2 Et2O Trace 
8 ZnCl2 Toluene No product 
9 ZnCl2 MeOH 80 
a Isolated yield. 
With the optimal conditions defined, a survey of the se-
candary amide for the reductive cycloaddition was carried 
out (Table 2). N-Alkyl substituents such as Me, phenethyl, 
and allyl groups were tolerated (Entries 2～4). In the latter 
case diene 2 reacted preferably with the amide over the 
terminal alkene. The use of a benzyl group or a secondary 
alkyl substituent (i-Pr) led to diminished yields (Entries 5 
and 6) probably because of the increased steric hindrance. 
Note that amide 4g reacted successfully in the presence of 
an ester functionality (Entry 7). 
We next examined the effect of the aryl substituents on 
the reductive cycloaddition reaction (Entries 8～15). The 
reaction is compatible with the use of electron-donating 
substituents such as Me and OMe, and halogens such as F 
and Cl at various positions of the phenyl ring. The reason 
for the low yield of the 4-methoxylated substrate 4k is un-
clear.  
The reaction of N-n-butyl-2-naphthamide (4p) proceed-
ed smoothly to yield 3p in 76% yield (Entry 16). 
2-Thiophenoylamide (4q) was less efficient and afforded 
3q in only 22% yield (Entry 17). Note that Frost reported 
that 2-thiophenecarboxaldehyde failed to undergo the 
three-component aza-Diels-Alder reaction with the Dan-
ishefsky diene.[23]  
The chemoselectivity[24] is of great importance when it 
comes to the manipulation of structurally complex mole-
cules. But it has rarely been demonstrated in the 
aza-Diels-Alder reactions. In addition to the chemoselec-
tive reaction showed in Entry 7, further investigation re-
vealed that our one-pot reaction proceeded selectively in 
the presence of other potential dienophiles such as a cyano 
group, a ketone, and even an aldehyde (Entries 18～20). 
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Tf2O (1.1 equiv.), 2-F-Py (1.2 equiv.) 
CH2Cl2, 0 
oC, 30 min
Et3SiH (1.1 equiv.), r.t., 5 h
Et3N (2.0 equiv.), ZnCl2 (2.0 equiv.)
Danishefsky diene (2) (2.0 equiv.)





Entry R R1 Product Yielda/%
1 Ph n-Bu 3a 80 
2 Ph Me 3b 77 
3 Ph PhCH2CH2 3c 65 
4 Ph Allyl 3d 73 
5 Ph Bn 3e 42 
6 Ph i-Pr 3f 31 
7 Ph MeO2CCH2CH2 3g 68 
8 4-MeC6H4 n-Bu 3h 83 
9 3-MeC6H4 n-Bu 3i 81 
10 2-MeC6H4 n-Bu 3j 67 
11 4-MeOC6H4 n-Bu 3k 34 
12 3,4,5-(MeO)3C6H2 n-Bu 3l 70 
13 4-FC6H4 n-Bu 3m 69 
14 4-ClC6H4 n-Bu 3n 61 
15 2-ClC6H4 n-Bu 3o 56 
16 2-Naphth n-Bu 3p 76 
17 2-Thienyl n-Bu 3q 22 
18 4-NCC6H4 n-Bu 3r 43 
19 4-MeC(O)C6H4 n-Bu 3s 60b 
20 4-HC(O)C6H4 n-Bu 3t 58b 
21 n-C10H21 n-Bu 3u 45 
22 Me n-Bu 3v 43 
23 3,4-(MeO)2C6H3 Cl(CH2)4 3w 53 
24 3,4-(MeO)2C6H3 Br(CH2)4 3x 50 
25 3,4-(MeO)2C6H3 I(CH2)4 3y 32 
26 Me Cl(CH2)4 3z 42 
a Isolated yield. b Activation of amide was carried out at －78 ℃ for 1 h, then 
at 0 ℃ for 10 min, the reduction with Et3SiH was performed at r.t. for 5 h. 
Aliphatic secondary amides 4u and 4v also reacted suc-
cessfully to afford the corresponding dihydropyridinones 
3u and 3v in moderate yields (Entries 21～22). It is note-
worthy that the one-pot reductive cycloaddition tolerated 
amides bearing halo-substituted N-alkyl groups (4w～4z, 
Entries 23～26, cf. SI). Such chemoselectivity is important 
for further synthetic transformations. 
The additional advantage of this one-pot reaction over 
the traditional aza-Diels-Alder reaction was demonstrated 
by the chemoselective reductive cycloaddition of 4aa. Un-
der the standard reaction conditions, 4aa reacted to pro-
duce the desired 3aa in 49% yield (Scheme 3, Eq. 1). Such 
selectivity would be difficult to achieve by the traditional 






































Scheme 3  Chemoselective approach to 3aa 
To demonstrate the synthetic potential of the chemose-
lective aza-Diels-Alder reactions, the transformation of 
adducts to alkaloids lasubine I (5) and myrtine (6) were 
envisioned. Lasubine I (5) and myrtine (6) are quinoliz-
idine alkaloids isolated from the plant Lagerstroemia sub-
costata[25a] and Vaccinium myrtillus,[25b] respectively. 
Quinolizidine alkaloids are a class of natural products pos-
sessing numerous biological activities, such as antiinflam-
matory, antispasmodic, and diuretic properties.[26] The 
synthesis of quinolizidine alkaloids including lasubine I 
(5)[27] and myrtine[28] have attracted much attention. In the 
event, 2,3-dihydro-4-pyridone 3y, which is also available 
from chloride 3w (NaI in acetone, reflux, 15 h) in 99% 
yield, was treated with (TMS)3SiH (5 equiv.) and AIBN (3 
equiv.) in toluene (1.5 h, 80 ℃)[29] to afford the known 
quinolizidinone 8[27d] as the single diastereomer in 74% 
yield (Scheme 4). Reduction of 8 with L-          
Selectride[27d～27f,27h] afforded (±)-lasubine I (5) as a single 
diastereomer in 77% yield. The spectral data (1H and 13C 
NMR) of our synthetic product matches those reported.[27f] 
 
Scheme 4  Transformation of 2,3-dihydro-4-pyridone 3y to 
(±)-lasubine I (5) 
Similarly, 2,3-dihydro-4-pyridone 3z was converted to 
(±)-myrtine (6) by a two-step sequence (Scheme 5). Io-
dination (NaI, acetone, reflux, 12 h) of 3z produced 3ac in 
97% yield. Free-radical cyclization of iodide 3ac 
[(TMS)3SiH (5 equiv.), AIBN (3 equiv.), 1.5 h, 75 ℃] 
gave (±)-myrtine (6) as a single diastereomer in 78% 
yield. 
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hydrochloride salt
NaI, acetone
reflux, 12 h, 97%
(TMS)3SiH, AIBN
78% from 3ac
toluene, 1.5 h, 75 oC
3z X = Cl
3ac X = I
1 mol/L HCl
(6)(    )_+
HCl.
 
Scheme 5  Transformation of 2,3-dihydro-4-pyridone 3z to (±)-myrtine 
(6) 
3  Conclusions  
In summary, we have developed a one-pot procedure for 
the reductive cycloaddition of common secondary amides 
with the Danishefsky diene. The reaction is chemoselective 
for secondary amide without affecting sensitive carbonyl 
groups of aldehyde, ketone, ester and cyano group, and 
provides a rapid access to a variety of 1,2-disubstituted 
2,3-dihydro-4-pyridones. The new procedure also affords 
the advantage of allow accessing to functionalized dihy-
dropyridinones that are inaccessible selectively by the 
conventional aza-Diels-Alder reactions. The potential of 
the chemoselective aza-Diels-Alder reaction was demon-
strated by the short protecting-group-free total syntheses of 
racemic lasubine I and myrtine. 
3.1  Experimental section 
General  1H NMR and 13C NMR spectra were record-
ed on a Bruker spectrometer at a Bruker 400  (1H/400 MHz, 
13C/100 MHz) or Bruker 600 (1H/600 MHz, 13C/150 MHz) spec-
trometer, respectively. Chemical shifts (δ) are reported in 
ppm and referenced to internal standard Me4Si and solvent 
signals respectively (Me4Si, δ 0 for 
1H NMR and CDCl3, δ 
77.0 for 13C NMR). HRMS spectra were recorded on an 
ESI-TOF mass spectrometer. Melting points were deter-
mined on a Büchi M560 Automatic Melting Point appa-
ratus. Infrared spectra were measured with a Nicolet Avatar 
330 FT-IR spectrometer using film KBr pellet technique. 
Silica gel (300～400 mesh) was used for flash column 
chromatography (FC), eluting (unless otherwise stated) 
with ethyl acetate/hexane mixture. Trifluoromethanesul-
fonic anhydride (Tf2O) was distilled over phosphorous 
pentoxide and used within a week. Dichloromethane was 
distilled over calcium hydride under N2. Methanol was 
distilled over Mg under N2. 
3.1.1  General procedure for the one-pot synthesis of 
2,3-dihydro-4-pyridones from secondary amides 
Trifluoromethanesulfonic anhydride (Tf2O) (46 μL, 0.27 
mmol, 1.1 equiv.) was added dropwise to a cooled (0 ℃) 
solution of a secondary amide (0.25 mmol, 1.0 equiv.) and 
2-fluoropyridine (26 μL, 0.30 mmol, 1.2 equiv.) in di-
chloromethane (2.0 mL). After being stirred for 30 min at 
0 ℃, triethylsilane (44 μL, 0.28 mmol, 1.1 equiv.) was 
added at 0 ℃. The reaction mixture was warmed to room 
temperature and stirred for 5 h. The solvent was removed 
via a dry tube (anhydrous calcium chloride) under reduced 
pressure. To the residue were added successively CH3OH 
(2.0 mL freshly distilled over Mg), Et3N (70 μL, 0.50 
mmol, 2.0 equiv.) and ZnCl2 (0.50 mL, 1.00 mmol, 2.0 
equiv., 1.0 mol/L in diethyl ether) at 0 ℃. The reaction 
mixture was stirred for 15 min and then to which Dan-
ishefsky’s diene (97 μL, 0.50 mmol, 2.0 equiv.) was added. 
After being stirred for 6 h at r.t., the reaction was quenched 
with 1.0 mL of 1.0 mol/L HCl and extracted with di-
chloromethane (10 mL×3). The combined organic layers 
were washed successively with a saturated aqueous solu-
tion of NaHCO3 (1.0 mL) and brine, dried over anhydrous 
Na2SO4, filtered, and concentrated under reduced pressure. 
The residue was purified by flash column chromatography 
on silica gel to afford the desired 2,3-dihydro-4-pyridone 
derivative. 
3.1.2  1-Butyl-2-phenyl-2,3-dihydropyridin-4(1H)-one (3a) 
Following the general procedure, the reductive 
cycloaddition of N-butylbenzamide (4a) (44 mg, 0.25 
mmol) gave, after flash column chromatography on silica 
gel [V(EtOAc) ∶ V(n-hexane) ＝ 1 ∶ 5], the known 
dihydropyridone 3a[17m] (46 mg, yield 80%) as a pale 
yellow oil. 1H NMR (400 MHz, CDCl3) δ: 0.88 (t, J＝7.3 
Hz, 3H), 1.19～1.35 (m, 2H), 1.47～1.55 (m, 2H), 2.67 
(dd, J＝16.4, 7.8 Hz, 1H), 2.87 (dd, J＝16.4, 7.0 Hz, 1H), 
3.06～3.10 (m, 2H), 4.61 (dd, J＝7.8, 7.0 Hz, 1H), 5.01 (d, 
J＝7.5 Hz, 1H), 7.15 (d, J＝7.5 Hz, 1H), 7.28～7.37 (m, 
5H); 13C NMR (100 MHz, CDCl3) δ: 13.6, 19.7, 30.7, 43.7, 
53.3, 60.9, 97.9, 126.8 (2C), 128.1, 128.9 (2C), 138.7, 
154.0, 190.0; IR (film) νmax: 3028, 2958, 2929, 2872, 1636, 
1593, 1579, 1456, 1384, 1350, 1216, 1174, 1040, 940   
cm－1; HRMS (ESI) calcd for [C15H19NONa]
＋ (M＋Na＋) 
252.1359; found 252.1365. 
3.1.3  1-Methyl-2-phenyl-2,3-dihydropyridin-4(1H)-one (3b) 
Following the general procedure, the reductive 
cycloaddition of N-methylbenzamide (4b) (34 mg, 0.25 
mmol) gave, after flash column chromatography on silica 
gel [V(EtOAc) ∶ V(n-hexane) ＝ 1 ∶ 2], the known 
dihydropyridone 3b[18b] (36 mg, yield 77%) as a pale 
yellow solid, m.p. 107～109 ℃; 1H NMR (400 MHz, 
CDCl3) δ: 2.69 (dd, J＝16.4, 9.4 Hz, 1H), 2.82 (dd, J＝
16.4, 6.8 Hz, 1H), 2.83 (s, 3H), 4.48 (dd, J＝9.4, 6.8 Hz, 
1H), 5.02 (d, J＝7.6 Hz, 1H), 7.10 (d, J＝7.6 Hz, 1H), 
7.28～7.40 (m, 5H); 13C NMR (100 MHz, CDCl3) δ: 41.3, 
43.8, 63.6, 98.3, 126.9 (2C), 128.3, 129.0 (2C), 138.7, 
155.1, 190.4; IR (film) νmax: 3028, 2919, 2851, 1635, 1591, 
1419, 1371, 1344, 1182, 1068, 978, 903 cm－1; HRMS 
(ESI) calcd for [C12H13NONa]
＋  (M＋Na＋ ) 210.0889; 
found 210.0893.  
3.1.4  1-Phenethyl-2-phenyl-2,3-dihydropyridin-4(1H)-one  
(3c) 
Following the general procedure, the reductive cycload-
dition of N-phenethylbenzamide (4c) (56 mg, 0.25 mmol) 
gave, after flash column chromatography on silica gel 
[V(EtOAc)∶V(n-hexane)＝1∶5], the desired dihydro-
pyridone 3c (45 mg, yield 65%) as a pale yellow oil. 1H 
NMR (400 MHz, CDCl3) δ: 2.65 (dd, J＝16.4, 8.3 Hz, 
1H), 2.73～2.85 (m, 3H), 3.27～3.37 (m, 2H), 4.53 (dd,  
J＝8.3, 6.9 Hz, 1H), 4.97 (d, J＝7.6 Hz, 1H), 7.02 (d, J＝
7.6 Hz, 1H), 7.04～7.08 (m, 2H), 7.24～7.39 (m, 8H); 13C 
NMR (100 MHz, CDCl3) δ: 30.6, 43.7, 55.0, 61.5, 98.5, 
126.8 (2C), 127.0 (2C), 128.3 (2C), 128.7 (2C), 129.0 
(2C), 137.8, 138.6, 153.8, 190.2; IR (film) νmax: 3025, 
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2921, 2852, 1637, 1578, 1453, 1360, 1162, 1043, 902, 834 
cm－1; HRMS (ESI) calcd for [C19H19NONa]
＋ (M＋Na＋) 
300.1359; found 300.1362. 
3.1.5  1-Allyl-2-phenyl-2,3-dihydropyridin-4(1H)-one (3d) 
Following the general procedure, the reductive cycload-
dition of N-allylbenzamide (4d) (40 mg, 0.25 mmol) gave, 
after flash column chromatography on silica gel 
[V(EtOAc)∶V(n-hexane)＝1∶5], the known dihydro-
pyridone 3d[17c] (39 mg, yield 73%) as a pale yellow oil. 1H 
NMR (400 MHz, CDCl3) δ: 2.70 (dd, J＝16.5, 8.4 Hz 1H), 
2.86 (dd, J＝16.5, 7.0 Hz, 1H), 3.53～3.61 (m, 1H), 
3.68～3.78 (m, 1H), 4.61 (dd, J＝8.4, 7.0 Hz, 1H), 5.07 (d, 
J＝7.7 Hz, 1H), 5.12～5.19 (m, 1H), 5.22～5.27 (m, 1H), 
5.70～5.81 (m, 1H), 7.17 (d, J＝7.7 Hz, 1H), 7.27～7.39 
(m, 5H); 13C NMR (100 MHz, CDCl3) δ: 43.7, 55.5, 61.1, 
98.9, 119.0, 126.9 (2C), 128.2, 129.0 (2C), 132.6, 138.7, 
153.8, 190.3; IR (film) νmax: 3058, 3030, 2918, 2851, 1639, 
1590, 1452, 1381, 1354, 1219, 1163, 1040, 993, 931 cm－1; 
HRMS (ESI) calcd for [C14H15NONa]
＋  (M ＋ Na ＋ ) 
236.1046; found 236.1047. 
3.1.6  1-Benzyl-2-phenyl-2,3-dihydropyridin-4(1H)-one (3e) 
Following the general procedure, the reductive cycload-
dition of N-benzylbenzamide (4e) (53 mg, 0.25 mmol) 
gave, after flash column chromatography on silica gel 
[V(EtOAc)∶V(n-hexane)＝1∶5], the known dihydro-
pyridone 3e[17c] (28 mg, yield 42%) as a pale yellow oil. 1H 
NMR (400 MHz, CDCl3) δ: 2.69 (dd, J＝16.5, 8.1 Hz, lH), 
2.81 (dd, J＝16.5, 7.1 Hz, 1H), 4.12 (d, J＝15.1 Hz, 1H), 
4.34 (d, J＝15.1 Hz, 1H), 4.50 (dd, J＝8.1, 7.1 Hz, 1H), 
5.09 (d, J＝7.7 Hz, 1H), 7.11～7.15 (m, 2H), 7.23～7.39 
(m, 9H); 13C NMR (100 MHz, CDCl3) δ: 43.7, 57.2, 60.8, 
98.8, 127.1 (2C), 127.7 (2C), 128.2, 128.3, 128.9 (2C), 
129.0 (2C), 135.9, 138.6, 154.1, 190.3; IR (film) νmax: 
3029, 2922, 2852, 1640, 1589, 1494, 1450, 1381, 1356, 
1208, 1157, 1040, 951 cm－1; HRMS (ESI) calcd for 
[C18H17NONa]
＋(M＋Na＋) 286.1202; found 286.1205. 
3.1.7  1-Isopropyl-2-phenyl-2,3-dihydropyridin-4(1H)-one 
(3f) 
Following the general procedure, the reductive 
cycloaddition of N-isopropylbenzamide (4f) (41 mg, 0.25 
mmol) gave, after flash column chromatography on silica 
gel [V(EtOAc) ∶ V(n-hexane) ＝ 1 ∶ 2], the known 
dihydropyridone 3f[17c] (17 mg, yield 31%) as a pale 
yellow oil. 1H NMR (400 MHz, CDCl3) δ: 1.13 (d, J＝6.5 
Hz, 3H), 1.24 (d, J＝6.8 Hz, 3H), 2.65 (dd, J＝16.4, 7.8 
Hz, 1H), 2.87 (dd, J＝16.4, 6.9 Hz, 1H), 3.32～3.42 (m, 
1H), 4.64 (dd, J＝7.8, 6.9 Hz, 1H), 5.09 (d, J＝7.6 Hz, 
1H), 7.27 (d, J＝7.6 Hz, 1H), 7.29～7.37 (m, 5H); 13C 
NMR (100 MHz, CDCl3) δ: 21.5, 21.6, 44.1, 52.5, 61.1, 
98.7, 126.6 (2C), 128.1, 129.0 (2C), 139.7, 149.9, 190.1; 
IR (film) νmax: 3029, 2971, 2926, 1638, 1578, 1494, 1452, 
1404, 1300, 1253, 1226, 1184, 1158, 1061, 978, 925 cm－1; 
HRMS (ESI) calcd for [C14H17NONa]
＋  (M ＋ Na ＋ ) 
238.1202; found 238.1203. 
3.1.8  Methyl 3-(4-oxo-2-phenyl-3,4-dihydropyridin-1(2H)- 
yl) propanoate (3g) 
Following the general procedure, the reductive cycload-
dition of methyl 3-benzamidopropanoate (4g) (52 mg, 0.25 
mmol) gave, after flash column chromatography on silica 
gel [V(EtOAc)∶V(n-hexane)＝1∶2], the desired dihy-
dropyridone 3g (44 mg, yield 68%) as a pale yellow oil. 1H 
NMR (400 MHz, CDCl3) δ: 2.40～2.58 (m, 2H), 2.66 (dd, 
J＝16.4, 7.7 Hz, 1H), 2.86 (dd, J＝16.4, 6.9 Hz, 1H), 
3.31～3.41 (m, 1H), 3.47～3.56 (m, 1H), 3.67 (s, 3H), 
4.64 (dd, J＝7.7, 6.9 Hz, 1H), 5.03 (d, J＝7.7 Hz, 1H), 
7.21 (d, J＝7.7 Hz, 1H), 7.28～7.39 (m, 5H); 13C NMR 
(100 MHz, CDCl3) δ: 33.2, 43.7, 49.0, 51.9, 60.8, 98.9, 
126.7 (2C), 128.3, 129.0 (2C), 138.4, 153.9, 171.2, 190.0; 
IR (film) νmax: 3026, 2950, 2921, 2850, 1735, 1639, 1592, 
1494, 1442, 1384, 1257, 1199, 1164, 1053, 982, 839 cm－1; 
HRMS (ESI) calcd for [C15H17NO3Na]
＋  (M＋Na ＋ ) 
282.1101; found 282.1104. 
3.1.9  1-Butyl-2-(p-tolyl)-2,3-dihydropyridin-4(1H)-one 
(3h) 
Following the general procedure, the reductive cycload-
dition of N-butyl-4-methylbenzamide (4h) (48 mg, 0.25 
mmol) gave, after flash column chromatography on silica 
gel [V(EtOAc)∶V(n-hexane)＝1∶5], the desired dihy-
dropyridone 3h (50 mg, yield 83%) as a pale yellow oil. 1H 
NMR (400 MHz, CDCl3) δ: 0.88 (t, J＝7.3 Hz, 3H), 
1.18～1.34 (m, 2H), 1.45～1.54 (m, 2H), 2.33 (s, 3H), 
2.66 (dd, J＝16.4, 8.2 Hz 1H), 2.84 (dd, J＝16.4, 7.0 Hz, 
1H), 3.04～3.10 (m, 2H), 4.58 (dd, J＝8.2, 7.0 Hz, 1H), 
5.00 (d, J＝7.5 Hz, 1H), 7.13～7.22 (m, 5H); 13C NMR 
(100 MHz, CDCl3) δ: 13.6, 19.7, 21.0, 30.7, 43.8, 53.2, 
60.7, 97.8, 126.8 (2C), 129.5 (2C), 135.7, 137.9, 154.0, 
190.2; IR (film) νmax: 3020, 2958, 2928, 2868, 1641, 1592, 
1512, 1382, 1347, 1257, 1214, 1171, 1113, 1082, 985, 817 
cm－1; HRMS (ESI) calcd for [C16H21NONa]
＋ (M＋Na＋) 
266.1515; found 266.1521. 
3.1.10  1-Butyl-2-(m-tolyl)-2,3-dihydropyridin-4(1H)-one 
(3i) 
Following the general procedure, the reductive cycload-
dition of N-butyl-3-methylbenzamide (4i) (48 mg, 0.25 
mmol) gave, after flash column chromatography on silica 
gel [V(EtOAc)∶V(n-hexane)＝1∶5], the desired dihy-
dropyridone 3i (49 mg, yield 81%) as a pale yellow oil. 1H 
NMR (400 MHz, CDCl3) δ: 0.88 (t, J＝7.3 Hz, 3H), 
1.18～1.38 (m, 2H), 1.46～1.55 (m, 2H), 2.35 (s, 3H), 
2.66 (dd, J＝16.4, 8.0 Hz, 1H), 2.86 (dd, J＝16.4, 7.0 Hz, 
1H), 3.05～3.11 (m, 2H), 4.57 (dd, J＝8.0, 7.0 Hz, 1H), 
5.01 (d, J＝7.6 Hz, 1H), 7.06～7.13 (m, 3H), 7.15 (d, J＝
7.6 Hz, 1H), 7.20～7.26 (m, 1H); 13C NMR (100 MHz, 
CDCl3) δ: 13.5, 19.6, 21.4, 30.7, 43.6, 53.2, 60.8, 97.8, 
123.8, 127.4, 128.7, 128.8, 138.6 (2 C), 154.0, 190.0; IR 
(film) νmax: 3026, 2958, 2927, 2867, 1640, 1588, 1457, 
1382, 1346, 1290, 1217, 1173, 1080, 934, 877 cm－1; 
HRMS (ESI) calcd for [C16H21NONa]
＋  (M ＋ Na ＋ ) 
266.1515; found 266.1521. 
3.1.11  1-Butyl-2-(o-tolyl)-2,3-dihydropyridin-4(1H)-one 
(3j) 
Following the general procedure, the reductive cycload-
dition of N-butyl-2-methylbenzamide (4j) (48 mg, 0.25 
mmol) gave, after flash column chromatography on silica 
gel [V(EtOAc)∶V(n-hexane)＝1∶5], the desired dihy-
dropyridone 3j (41 mg, yield 67%) as a pale yellow oil. 1H 
NMR (400 MHz, CDCl3) δ: 0.87 (t, J＝7.3 Hz, 3H), 
1.16～1.35 (m, 2H), 1.41～1.52 (m, 2H), 2.34 (s, 3H), 
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2.61 (dd, J＝16.5, 9.0 Hz, 1H), 2.79 (dd, J＝16.5, 7.2 Hz, 
1H), 3.02～3.08 (m, 2H), 4.86 (dd, J＝9.0, 7.2 Hz, 1H), 
5.02 (d, J＝7.5 Hz, 1H), 7.16～7.24 (m, 4H), 7.31～7.35 
(m, 1H); 13C NMR (100 MHz, CDCl3) δ: 13.6, 19.0, 19.7, 
30.5, 42.3, 53.1, 57.3, 97.7, 126.4, 126.5, 127.8, 131.2, 
134.8, 136.4, 154.7, 190.0; IR (film) νmax: 3064, 3018, 
2957, 2925, 2862, 1640, 1588, 1456, 1382, 1291, 1254, 
1216, 1172, 1044, 902 cm－1; HRMS (ESI) calcd for 
[C16H21NONa]
＋ (M＋Na＋) 266.1515; found 266.1515. 
3.1.12 1-Butyl-2-(p-methoxyphenyl)-2,3-dihydropyridin- 
4(1H)-one (3k) 
Following the general procedure, the reductive cycload-
dition of N-butyl-4-methoxybenzamide (4k) (52 mg, 0.25 
mmol) gave, after flash column chromatography on silica 
gel [V(EtOAc)∶V(n-hexane)＝1∶5], the desired dihy-
dropyridone 3k (22 mg, yield 34%) as a pale yellow oil. 1H 
NMR (400 MHz, CDCl3) δ: 0.88 (t, J＝7.3 Hz, 3H), 
1.16～1.36 (m, 2H), 1.44～1.54 (m, 2H), 2.66 (dd, J＝
16.4, 8.4 Hz, 1H), 2.82 (dd, J＝16.4, 6.8 Hz, 1H), 3.03～
3.09 (m, 2H), 3.80 (s, 3H), 4.56 (dd, J＝8.4, 6.8 Hz, 1H), 
5.00 (d, J＝7.5 Hz, 1H), 6.85～6.91 (m, 2H), 7.14 (d, J＝
7.5 Hz, 1H), 7.20～7.25 (m, 2H); 13C NMR (100 MHz, 
CDCl3) δ: 13.6, 19.7, 30.8, 43.9, 53.1, 55.3, 60.5, 97.9, 
114.3 (2C), 128.1 (2C), 130.8, 154.0, 159.5, 190.4; IR 
(film) νmax: 3006, 2958, 2922, 2853, 1640, 1588, 1511, 
1459, 1381, 1295, 1251, 1214, 1173, 1111, 1032, 902, 832 




282.1465; found 282.1467. 
3.1.13  1-Butyl-2-(3,4,5-trimethoxyphenyl)-2,3-dihydro- 
pyridin-4(1H)-one (3l) 
Following the general procedure, the reductive cycload-
dition of N-butyl-3,4,5-trimethoxybenzamide (4l) (67 mg, 
0.25 mmol) gave, after flash column chromatography on 
silica gel [V(EtOAc)∶V(n-hexane)＝1∶2], the desired 
dihydropyridone 3l (56 mg, yield 70%) as a pale yellow 
oil. 1H NMR (400 MHz, CDCl3) δ: 0.89 (t, J＝7.3 Hz, 3H), 
1.20-1.34 (m, 2H), 1.49～1.54 (m, 2H), 2.66 (dd, J＝16.5, 
8.0 Hz, 1H), 2.86 (dd, J＝16.5, 7.2 Hz, 1H), 3.08～3.13 
(m, 2H), 3.84 (s, 9H), 4.54 (dd, J＝8.0, 7.2 Hz, 1H), 4.99 
(d, J＝7.3 Hz, 1H), 6.51 (s, 2H), 7.18 (d, J＝7.3 Hz, 1H); 
13C NMR (100 MHz, CDCl3) δ: 13.5, 19.7, 30.8, 43.5, 
53.3, 56.1(2C), 60.7, 61.1, 97.7, 103.9 (2C), 134.4, 137.8, 
153.5 (2C), 154.4, 190.3; IR (film) νmax: 3073, 2956, 2933, 
2866, 2834, 1638, 1590, 1506, 1459, 1423, 1327, 1240, 
1173, 1126, 1007, 835 cm－1; HRMS (ESI) calcd for 
[C18H25NO4Na]
＋ (M＋Na＋) 342.1676; found 342.1674. 
3.1.14  1-Butyl-2-(p-fluorophenyl)-2,3-dihydropyridin- 
4(1H)-one (3m) 
Following the general procedure, the reductive cycload-
dition of N-butyl-4-fluorobenzamide (4m) (49 mg, 0.25 
mmol) gave, after flash column chromatography on silica 
gel [V(EtOAc)∶V(n-hexane)＝1∶5], the desired dihy-
dropyridone 3m (43 mg, yield 69%) as a pale yellow oil. 
1H NMR (400 MHz, CDCl3) δ: 0.89 (t, J＝7.3 Hz, 3H), 
1.18～1.38 (m, 2H), 1.46～1.56 (m, 2H), 2.62 (dd, J＝
16.4, 7.4 Hz, 1H), 2.88 (dd, J＝16.4, 7.0 Hz, 1H), 3.01～
3.15 (m, 2H), 4.61 (dd, J＝7.4, 7.0 Hz, 1H), 5.01 (d, J＝
7.6 Hz, 1H), 7.01～7.07 (m, 2H), 7.16 (d, J＝7.6 Hz, 1H), 
7.25～7.31 (m, 2H); 13C NMR (100 MHz, CDCl3) δ: 13.6, 
19.7, 30.8, 43.6, 53.3, 60.2, 98.0, 115.9 (d, JF-C＝21.7 Hz, 
2C), 128.4 (d, JF-C＝8.1 Hz, 2C), 134.6 (d, JF-C＝3.3 Hz), 
153.9, 162.4 (d, JF-C＝249.0 Hz), 189.8; IR (film) νmax: 
3037, 2959, 2923, 2854, 1640, 1585, 1508, 1459, 1381, 
1295, 1221, 1166, 1041, 836 cm－1; HRMS (ESI) calcd for 
[C15H18FNONa]
＋ (M＋Na＋) 270.1265; found 270.1267. 
3.1.15 1-Butyl-2-(p-chlorophenyl)-2,3-dihydropyridin- 
4(1H)-one (3n) 
Following the general procedure, the reductive cycload-
dition of N-butyl-4-chlorobenzamide (4n) (53 mg, 0.25 
mmol) gave, after flash column chromatography on silica 
gel [V(EtOAc)∶V(n-hexane)＝1∶5], the desired dihy-
dropyridone 3n (40 mg, yield 61%) as a pale yellow oil. 1H 
NMR (400 MHz, CDCl3) δ: 0.89 (t, J＝7.3 Hz, 3H), 
1.20～1.38 (m, 2H), 1.46～1.56 (m, 2H), 2.60 (dd,  J＝
16.4, 7.1 Hz, 1H), 2.89 (dd, J＝16.4, 7.2 Hz, 1H), 3.00～
3.16 (m, 2H), 4.59 (dd, J＝7.2, 7.1 Hz, 1H), 5.01 (d, J＝
7.6 Hz, 1H), 7.16 (d, J＝7.6 Hz, 1H), 7.22～7.36 (m, 2H), 
7.30～7.35 (m, 2H); 13C NMR (100 MHz, CDCl3) δ: 13.6, 
19.6, 30.7, 43.4, 53.4, 60.1, 98.1, 128.1 (2C), 129.1 (2C), 
133.9, 137.3, 153.8, 189.5; IR (film) νmax: 3031, 2958, 
2925, 2866, 1639, 1589, 1489, 1458, 1382, 1214, 1170, 
1088, 1014, 982, 825 cm－ 1; HRMS (ESI) calcd for 
[C15H18ClNONa]
＋ (M＋Na＋) 286.0969; found 286.0968. 
3.1.16  1-Butyl-2-(o-chlorophenyl)-2,3-dihydropyridin- 
4(1H)-one (3o) 
Following the general procedure, the reductive cycload-
dition of N-butyl-2-chlorobenzamide (4o) (53 mg, 0.25 
mmol) gave, after flash column chromatography on silica 
gel [V(EtOAc)∶V(n-hexane)＝1∶5], the desired dihy-
dropyridone 3o (37 mg, yield 56%) as a pale yellow oil. 1H 
NMR (400 MHz, CDCl3) δ: 0.91 (t, J＝7.3 Hz, 3H), 
1.22～1.42 (m, 2H), 1.50～1.58 (m, 2H), 2.65 (dd, J＝
16.5, 5.6 Hz, 1H), 2.97 (dd, J＝16.5, 7.9 Hz, 1H), 3.01～
3.18 (m, 2H), 5.00 (d, J＝7.6 Hz, 1H), 5.12 (dd, J＝7.9, 
5.6 Hz, 1H), 7.20～7.26 (m, 3H), 7.37～7.41 (m, 2H); 13C 
NMR (100 MHz, CDCl3) δ: 13.6, 19.7, 30.8, 41.2, 53.8, 
56.9, 97.7, 127.2, 127.7, 129.2, 130.3, 132.6, 135.6, 154.1, 
189.4; IR (film) νmax: 3064, 2958, 2923, 2855, 1641, 1591, 
1463, 1383, 1347, 1214, 1171, 1041 cm－1; HRMS (ESI) 
calcd for [C15H18ClNONa]
＋ (M＋Na＋) 286.0969; found 
286.0971. 
3.1.17  1-Butyl-2-(naphthalen-2-yl)-2,3-dihydropyridin- 
4(1H)-one (3p) 
Following the general procedure, the reductive cycload-
dition of N-butyl-2-naphthamide (4p) (57 mg, 0.25 mmol) 
gave, after flash column chromatography on silica gel 
[V(EtOAc)∶V(n-hexane)＝1∶5], the desired dihydro-
pyridone 3p (53 mg, yield 76%) as a pale yellow oil. 1H 
NMR (400 MHz, CDCl3) δ: 0.85 (t, J＝7.3 Hz, 3H), 
1.16～1.36 (m, 2H), 1.44～1.62 (m, 2H), 2.88～2.99 (m, 
2H), 3.01～3.20 (m, 2H), 5.06 (d, J＝7.6 Hz, 1H), 5.40 
(dd, J＝7.7, 7.6 Hz, 1H), 7.30 (d, J＝7.6 Hz, 1H), 7.40～
7.48 (m, 2H), 7.49～7.58 (m, 2H), 7.79～7.85 (m, 1H), 
7.88～7.93 (m, 1H), 8.00～8.07 (m, 1H); 13C NMR (100 
MHz, CDCl3) δ: 13.6, 19.8, 31.0, 42.4, 53.6, 58.3, 97.7, 
122.5, 124.7, 125.3, 125.8, 126.5, 128.9, 129.4, 130.3, 
132.8, 134.4, 154.4, 190.0; IR (film) νmax: 3049, 2958, 
2927, 2668, 1640, 1588, 1511, 1461, 1371, 1323, 1261, 
 
化 学 学 报 研究论文  
  
 
Acta Chim. Sinica 2015, 73, 705—715 © 2015 Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences http://sioc-journal.cn    711 
1217, 1178, 1042, 965, 931, 905, 859, 799 cm－1; HRMS 
(ESI) calcd for [C19H21NONa]
＋  (M＋Na＋ ) 302.1515; 
found 302.1520. 
3.1.18  1-Butyl-2-(thiophen-2-yl)-2,3-dihydropyridin- 
4(1H)-one (3q) 
Following the general procedure, the reductive cycload-
dition of N-butylthiophene-2-carboxamide (4q) (46 mg, 
0.25 mmol) gave, after flash column chromatography on 
silica gel [V(EtOAc)∶V(n-hexane)＝1∶5], the desired 
dihydropyridone 3q (13 mg, yield 22%) as a pale yellow 
oil. 1H NMR (400 MHz, CDCl3) δ: 0.93 (t, J＝7.3 Hz, 3H), 
1.26～1.42 (m, 2H), 1.53～1.66 (m, 2H), 2.71 (dd, J＝
16.3, 5.8 Hz, 1H), 2.97 (dd, J＝16.3, 6.8 Hz, 1H), 3.07～
3.26 (m, 2H), 4.87 (dd, J＝6.8, 5.8 Hz, 1H), 5.05 (d, J＝
7.5 Hz, 1H), 6.92～6.97 (m, 1H), 6.99～7.05 (m, 2H), 
7.22～7.26 (m, 1H); 13C NMR (100 MHz, CDCl3) δ: 13.6, 
19.7, 31.1, 43.7, 53.4, 56.4, 98.4, 125.4, 126.1, 126.5, 
141.5, 152.8, 189.7; IR (film) νmax: 3074, 2953, 2926, 
2856, 1720, 1641, 1588, 1460, 1377, 1313, 1213, 1170, 
1077, 1043, 970, 849 cm－ 1; HRMS (ESI) calcd for 
[C13H17NOSNa]
＋ (M＋Na＋) 258.0923; found 258.0928. 
3.1.19  1-Butyl-2-(p-cyanophenyl)-2,3-dihydropyridin- 
4(1H)-one (3r) 
Following the general procedure, the reductive cycload-
dition of N-butyl-4-cyanobenzamide (4r) (51 mg, 0.25 
mmol) gave, after flash column chromatography on silica 
gel [V(EtOAc)∶V(n-hexane)＝1∶2], the desired dihy-
dropyridone 3r (27 mg, yield 43%) as a pale yellow oil. 1H 
NMR (400 MHz, CDCl3) δ: 0.91 (t, J＝7.3 Hz, 3H), 
1.23～1.41 (m, 2H), 1.49～1.60 (m, 2H), 2.58 (dd, J＝
16.4, 5.8 Hz, 1H), 2.95～3.10 (m, 2H), 3.13～3.23 (m, 
1H), 4.68 (dd, J＝7.1, 5.8 Hz, 1H), 5.03 (d, J＝7.6 Hz, 
1H), 7.20 (d, J＝7.6 Hz, 1H), 7.39～7.45 (m, 2H), 7.63～
7.70 (m, 2H); 13C NMR (100 MHz, CDCl3) δ: 13.6, 19.7, 
30.9, 42.9, 53.9, 60.2, 98.5, 112.1, 118.2, 127.4 (2C), 132.8 
(2C), 144.1, 153.6, 188.8; IR (film) νmax: 3034, 2959, 2926, 
2868, 2228, 1639, 1588, 1460, 1383, 1264, 1215, 1171, 
1040, 982, 934, 836 cm － 1; HRMS (ESI) calcd for 
[C16H18N2ONa]
＋ (M＋Na＋) 277.1311; found 277.1312. 
3.1.20  2-(p-Acetylphenyl)-1-butyl-2,3-dihydropyridin- 
4(1H)-one (3s) 
Following the general procedure, the activating 
temperature was changed to －78 ℃, the reductive cy-
cloaddition of N-butyl-4-acetylbenzamide (4s) (55 mg, 
0.25 mmol) gave, after flash column chromatography on 
silica gel [V(EtOAc)∶V(n-hexane)＝1∶5], the desired 
dihydropyridone 3s (41 mg, yield 60%) as a pale yellow 
oil. 1H NMR (400 MHz, CDCl3) δ: 0.90 (t, J＝7.3 Hz, 3H), 
1.20～1.41 (m, 2H), 1.48～1.58 (m, 2H), 2.63 (dd, J＝
16.4, 6.9 Hz, 1H), 2.60 (s, 3H), 2.93 (dd, J＝16.4, 7.2 Hz, 
1H), 3.02～3.20 (m, 2H), 4.68 (dd, J＝7.2, 6.9 Hz, 1H), 
5.03 (d, J＝7.5 Hz, 1H), 7.18 (d, J＝7.6 Hz, 1H), 7.36～
7.44 (m, 2H), 7.92～7.98 (m, 2H); 13C NMR (100 MHz, 
CDCl3) δ: 13.5, 19.6, 26.5, 30.8, 43.2, 53.6, 60.4, 98.3, 
126.9 (2C), 129.0 (2C), 136.9, 143.9, 153.7, 189.2, 197.3; 
IR (film) νmax: 3037, 2959, 2927, 2866, 1683, 1639, 1589, 
1459, 1411, 1358, 1266, 1214, 1171, 1079, 960, 833 cm－1; 
HRMS (ESI) calcd for [C17H21NO2Na]
＋  (M＋Na ＋ ) 
294.1465; found 294.1465. 
3.1.21 1-Butyl-2-(p-formylphenyl)-2,3-dihydropyridin- 
4(1H)-one (3t) 
Following the general procedure, the activating 
temperature was changed to －78 ℃, the reductive cy-
cloaddition of N-butyl-4-formylbenzamide (4t) (51 mg, 
0.25 mmol) gave, after flash column chromatography on 
silica gel [V(EtOAc)∶V(n-hexane)＝1∶5], the desired 
dihydropyridone 3t (37 mg, yield 58%) as a pale yellow 
oil. 1H NMR (400 MHz, CDCl3) δ: 0.90 (t, J＝7.3 Hz, 3H), 
1.22～1.40 (m, 2H), 1.49～1.59 (m, 2H), 2.64 (dd, J＝
16.4, 6.4 Hz, 1H), 2.97 (dd, J＝16.4, 7.3 Hz, 1H), 3.02～
3.22 (m, 2H), 4.70 (dd, J＝7.3, 6.4 Hz, 1H), 5.04 (d, J＝
7.6 Hz, 1H), 7.19 (d, J＝7.6 Hz, 1H), 7.45～7.50 (m, 2H), 
7.86～7.91 (m, 2H), 10.01 (s, 1H); 13C NMR (100 MHz, 
CDCl3) δ: 13.6, 19.7, 30.9, 43.2, 53.8, 60.6, 98.5, 127.4 
(2C), 130.4 (2C), 136.3, 145.6, 153.7, 189.1, 191.1; IR 
(film) νmax: 3043, 2962, 2924, 2854, 1701, 1637, 1589, 
1458, 1383, 1298, 1210, 1170, 1045, 833 cm－1; HRMS 
(ESI) calcd for [C16H19NO2Na]
＋  (M＋Na＋) 280.1308; 
found 280.1307. 
3.1.22  1-Butyl-2-decyl-2,3-dihydropyridin-4(1H)-one 
(3u) 
Following the general procedure, the reductive cycload-
dition of N-butylundecanamide (4u) (60 mg, 0.25 mmol) 
gave, after flash column chromatography on silica gel 
[V(EtOAc)∶V(n-hexane)＝1∶5], the desired dihydro-
pyridone 3u (33 mg, yield 45%) as a pale yellow oil. 1H 
NMR (400 MHz, CDCl3) δ: 0.88 (t, J＝6.8 Hz, 3H), 0.97 
(t, J＝7.3 Hz, 3H), 1.19～1.45 (m, 17H), 1.54～1.64 (m, 
4H), 1.69～1.80 (m, 1H), 2.34 (dd, J＝16.3, 2.8 Hz, 1H), 
2.72 (dd, J＝16.3, 6.8 Hz, 1H), 3.12～3.26 (m, 2H), 
3.38～3.48 (m, 1H), 4.87 (d, J＝7.3 Hz, 1H), 6.92 (dd, J＝
7.3 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ: 13.6, 14.0, 
19.7, 22.6, 25.6, 28.5, 29.2, 29.4, 29.5 (3C), 31.8 (2C), 
39.3, 53.8, 56.5, 96.3, 152.3, 190.4; IR (film) νmax: 3028, 
2956, 2926, 2855, 1642, 1588, 1459, 1382, 1215, 1175  
cm－1; HRMS (ESI) calcd for [C19H35NONa]
＋ (M＋Na＋) 
316.2611; found 316.2618. 
3.1.23  1-Butyl-2-methyl-2,3-dihydropyridin-4(1H)-one 
(3v) 
Following the general procedure, the reductive cycload-
dition of N-butylacetamide (4v) (29 mg, 0.25 mmol) gave, 
after flash column chromatography on silica gel 
[V(EtOAc)∶V(n-hexane)＝1∶2], the desired dihydro-
pyridone 3v (18 mg, yield 43%) as a pale yellow oil. 1H 
NMR (400 MHz, CDCl3) δ: 0.96 (t, J＝7.3 Hz, 3H), 1.24 
(d, J＝6.7 Hz, 3H), 1.33～1.43 (m, 2H), 1.55～1.63 (m, 
2H), 2.22 (dd, J＝16.3, 4.4 Hz, 1H), 2.73 (dd, J＝16.3, 6.6 
Hz, 1H), 3.09～3.18 (m, 1H), 3.19～3.27 (m, 1H), 3.60～
3.69 (m, 1H), 4.90 (d, J＝7.5 Hz, 1H), 6.90 (d, J＝7.5 Hz, 
1H); 13C NMR (100 MHz, CDCl3) δ: 13.6, 15.2, 19.7, 31.4, 
42.2, 52.0, 53.1, 96.5, 152.3, 190.5; IR (film) νmax: 3031, 
2961, 2928, 2870, 1640, 1586, 1456, 1380, 1345, 1272, 
1220, 1177, 1118, 1029 cm－1; HRMS (ESI) calcd for 
[C10H17NONa]
＋ (M＋Na＋) 190.1202; found 190.1201. 
3.1.24  1-(4-Chlorobutyl)-2-(3,4-dimethoxyphenyl)-2,3- 
dihydropyridin-4(1H)-one (3w) 
Following the general procedure, the reductive cycload-
dition of N-(4-chlorobutyl)-3,4-dimethoxybenzamide (4w) 
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(544 mg, 2.00 mmol) gave, after flash column 
chromatography on silica gel [V(EtOAc)∶V(n-hexane)＝
1∶2], the known dihydropyridone 3w[27i] (342 mg, yield 
53%) as a pale yellow oil. 1H NMR (400 MHz, CDCl3) δ: 
1.62～1.80 (m, 4H), 2.70 (dd, J＝16.5, 9.0 Hz 1H), 2.82 
(dd, J＝16.5, 6.8 Hz, 1H), 3.04～3.18 (m, 2H), 3.45～3.55 
(m, 2H), 3.87 (s, 3H), 3.88 (s, 3H), 4.56 (dd, J＝9.0, 6.8 
Hz, 1H), 5.04 (d, J＝7.6 Hz, 1H), 6.81～6.88 (m, 3H), 
7.15 (d, J＝7.6 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ: 
25.6, 29.3, 43.9, 44.2, 52.5, 55.8, 55.9, 60.9, 98.3, 109.8, 
111.3, 119.4, 131.4, 149.0, 149.3, 153.8, 190.3; IR (film) 
νmax: 3072, 2919, 2849, 1638, 1584, 1515, 1459, 1385, 
1261, 1175, 1141, 1025, 871 cm－1; HRMS (ESI) calcd for 
[C17H22ClNO3Na]
＋ (M＋Na＋) 346.1180; found 346.1180. 
3.1.25  1-(4-Bromobutyl)-2-(3,4-dimethoxyphenyl)-2,3- 
dihydropyridin-4(1H)-one (3x) 
Following the general procedure, the reductive cycload-
dition of N-(4-bromobutyl)-3,4-dimethoxy- benzamide 
(4x) (315 mg, 1.00 mmol) gave, after flash column 
chromatography on silica gel [V(EtOAc)∶V(n-hexane)＝
1∶2], the desired dihydropyridone 3x (184 mg, yield 
50%) as a pale yellow oil. 1H NMR (400 MHz, CDCl3) δ: 
1.64～1.74 (m, 2H), 1.75～1.87 (m, 2H), 2.70 (dd, J＝
16.4, 9.2 Hz, 1H), 2.81 (dd, J＝16.4, 6.7 Hz, 1H), 3.03～
3.18 (m, 2H), 3.30～3.42 (m, 2H), 3.87 (s, 3H), 3.88 (s, 
3H), 4.55 (dd, J＝9.2, 6.7 Hz, 1H), 5.05 (d,  J＝7.7 Hz, 
1H), 6.81～6.89 (m, 3H), 7.13 (d, J＝7.7 Hz, 1H); 13C 
NMR (100 MHz, CDCl3) δ: 27.2, 29.5, 32.7, 44.0, 52.4, 
55.9, 56.0, 61.1, 98.6, 110.0, 111.4, 120.0, 131.1, 149.1, 
149.5, 153.8, 190.5; IR (film) νmax: 3069, 2925, 2853, 
1636, 1584, 1514, 1457, 1260, 1174, 1140, 1034  cm－1; 
HRMS (ESI) calcd for [C17H22BrNO3Na]
＋  (M＋Na＋ ) 
390.0675; found 390.0679. 
3.1.26  2-(3,4-Dimethoxyphenyl)-1-(4-iodobutyl)-2,3- 
dihydropyridin-4(1H)-one (3y) 
Following the general procedure, the reductive cycload-
dition of N-(4-iodobutyl)-3,4-dimethoxybenzamide (4y) 
(363 mg, 1.00 mmol) gave, after flash column 
chromatography on silica gel [V(EtOAc)∶V(n-hexane)＝
1∶2], the known dihydropyridone 3y[27i] (133 mg, yield 
32%) as a pale yellow oil. 1H NMR (400 MHz, CDCl3) δ: 
1.60～1.88 (m, 4H), 2.70 (dd, J＝16.4, 9.2 Hz, 1H), 2.81 
(dd, J＝16.4, 6.7 Hz, 1H), 3.01～3.20 (m, 4H), 3.88 (s, 
3H), 3.89 (s, 3H), 4.56 (dd, J＝9.2, 6.7 Hz, 1H), 5.04 (d,  
J＝7.6 Hz, 1H), 6.82～6.90 (m, 3H), 7.13 (d, J＝7.6 Hz, 
1H); 13C NMR (100 MHz, CDCl3) δ: 5.5, 29.4, 30.1, 44.0, 
52.1, 55.9, 56.0, 61.0, 98.5, 109.9, 111.4, 119.5, 131.1, 
149.1, 149.5, 153.9, 190.3; IR (film) νmax: 3009, 2921, 
2852, 1631, 1571, 1514, 1462, 1260, 1139, 1089, 1023  
cm－1; HRMS (ESI) calcd for [C17H22INO3Na]
＋ (M＋Na＋) 
438.0537; found 438.0529. 
3.1.27  1-(4-Chlorobutyl)-2-methyl-2,3-dihydropyridin- 
4(1H)-one (3z) 
Following the general procedure, the reductive cycload-
dition of N-(4-chlorobutyl)acetamide (4z) (240 mg, 1.60 
mmol) gave, after flash column chromatography on silica 
gel [V(EtOAc)∶V(n-hexane)＝1∶2], the desired dihy-
dropyridone 3z (135 mg, yield 42%) as a pale yellow oil. 
1H NMR (400 MHz, CDCl3) δ: 1.25 (d, J＝6.7 Hz, 3H), 
1.73～1.90 (m, 4H), 2.23 (dd, J＝16.3, 4.0 Hz 1H), 2.74 
(dd, J＝16.3, 6.6 Hz, 1H), 3.13～3.24 (m, 1H), 3.25～3.35 
(m, 1H), 3.56～3.62 (m, 2H), 3.63～3.71 (m, 1H), 4.91 (d, 
J＝7.4 Hz, 1H), 6.91 (d, J＝7.4 Hz, 1H); 13C NMR (100 
MHz, CDCl3) δ: 15.1, 26.6, 29.3, 42.4, 44.2, 51.9, 52.6, 
96.9, 152.1, 190.5; IR (film) νmax: 3081, 2921, 2852, 1637, 
1585, 1453, 1382, 1236 cm－1; HRMS (ESI) calcd for 
[C10H16ClNONa]
＋ (M＋Na＋) 224.0813; found 224.0820. 
3.1.28  1-Butyl-2-(4-formyl-2-methylphenyl)-2,3- 
dihydropyridin-4(1H)-one (3aa) 
Following the general procedure, the activating 
temperature was changed to －78 ℃, the reductive cy-
cloaddition of N-butyl-4-formyl-2-methylbenzamide (4aa) 
(55 mg, 0.25 mmol) gave, after flash column 
chromatography on silica gel [V(EtOAc)∶V(n-hexane)＝
1∶2], the desired dihydropyridone 3aa (33 mg, yield 
49%) as a pale yellow oil. 1H NMR (400 MHz, CDCl3) δ: 
0.89 (t, J＝7.3 Hz, 3H), 1.20～1.38 (m, 2H), 1.44～1.54 
(m, 2H), 2.43 (s, 3H), 2.55 (dd, J＝16.4, 7.8 Hz, 1H), 2.87 
(dd, J＝16.4, 7.5 Hz, 1H), 2.97～3.06 (m, 1H), 3.07～3.16 
(m, 1H), 4.90 (dd, J＝7.8, 7.5 Hz, 1H), 5.05 (d, J＝7.6 Hz, 
1H), 7.24 (d, J＝7.6 Hz, 1H), 7.52～7.55 (m, 1H), 7.68～
7.75 (m, 2H), 9.98 (s, 1 H); 13C NMR (100 MHz, CDCl3) 
δ: 13.6, 19.1, 19.7, 30.6, 41.7, 53.6, 57.3, 98.2, 127.1, 
128.0, 132.4, 136.0 (2C), 143.4, 154.5, 189.2, 191.7; IR 
(film) νmax: 3046, 2958, 2927, 2869, 1692, 1638, 1590, 
1457, 1385, 1292, 1216, 1173, 1084, 774 cm－1; HRMS 
(ESI) calcd for [C17H21NO2Na]
＋  (M＋Na＋) 294.1465; 
found 294.1463. 
3.1.29  N-(4-Hydroxybutyl)-3,4-dimethoxybenzamide (9) 
To a solution of 3,4-dimethoxybenzoic acid (547 mg, 
3.00 mmol) and dimethylformamide (50 μL, 0.60 mmol) in 
dry toluene (10 mL) at 0 ℃ was added dropwise thio-
nylchloride (0.24 mL, 3.30 mmol). The mixture was heated 
to 70 ℃ and stirred for 2 h. The reaction was then cooled 
to 0 ℃ and diluted with acetonitrile (15 mL). To the re-
sulting mixture were added triethylamine (0.63 mL, 4.50 
mmol) and 4-amino-1-butanol (268 mg, 3.00 mmol) at 
0 ℃. The reaction mixture was warmed to room tempera-
ture and then heated under reflux for 12 h. The reaction 
was quenched with a saturated aqueous solution of Na-
HCO3 and extracted with CH2Cl2 (40 mL×4). The com-
bined organic layers were washed with brine, dried over 
anhydrous Na2SO4, filtered, and concentrated under re-
duced pressure. The residue was purified by flash chroma-
tography on silica gel [V(EtOAc)∶V(n-hexane)＝3∶1] to 
give compound 9 (698 mg, yield 92%) as a white solid, 
m.p. 92～93 ℃; 1H NMR (400 MHz, CDCl3) δ: 1.60～
1.66 (m, 2H), 1.66～1.73 (m, 2H), 2.87 (s, 1H), 3.44 (dd,  
J＝12.4, 6.5 Hz, 2H), 3.67 (t, J＝6.0 Hz, 2H), 3.87 (s, 3H), 
3.88 (s, 3H), 6.81 (d, J＝8.5 Hz, 1H), 6.93～7.00 (m, 1H), 
7.31～7.35 (m, 1H), 7.41～7.44 (m, 1H); 13C NMR (100 
MHz, CDCl3) δ: 26.2, 29.8, 39.8, 55.9 (2C), 62.1, 110.3, 
110.6, 119.5, 127.2, 148.8, 151.6, 167.3; IR (film) νmax: 
3315, 3078, 2937, 2866, 1632, 1580, 1549, 1508, 1462, 
1314, 1270, 1231, 1132, 1022, 879, 819 cm－1; HRMS 
(ESI) calcd for [C13H19NO4Na]
＋  (M＋Na＋) 276.1206; 
found 276.1203. 
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3.1.30  N-(4-Chlorobutyl)-3,4-dimethoxybenzamide (4w) 
To a solution of 9 (1.013 g, 4.00 mmol) in mixture of 
toluene (53 mL) and chloroform (7.5 mL) at 0 ℃ was 
added thionylchloride (0.44 mL, 6.00 mmol) and the reac-
tion was heated up to 60 ℃ for 2 h. The mixture was 
concentrated and the resulting residue was purified by 
flash chromatography on silica gel [V(EtOAc) ∶
V(n-hexane)＝1∶2] to give compound 4w (1.050 g, yield 
97%) as a white solid, mp 93～95 ℃. 1H NMR (400 
MHz, CDCl3) δ: 1.72～1.80 (m, 2H), 1.81～1.89 (m, 2H), 
3.43～3.49 (m, 2H), 3.57 (t, J＝6.4 Hz, 2H), 3.89 (s, 3H), 
3.90 (s, 3H), 6.52～6.58 (m, 1H), 6.84 (d, J＝8.5 Hz, 1H), 
7.30～7.33 (m, 1H), 7.42～7.44 (m, 1H); 13C NMR (100 
MHz, CDCl3) δ: 27.0, 29.8, 39.2, 44.5, 55.9 (2C), 110.2, 
110.5, 119.4, 127.1, 148.9, 151.6, 167.2; IR (film) νmax: 
3316, 3078, 2936, 2842, 1634, 1583, 1547, 1507, 1462, 
1310, 1269, 1230, 1182, 1131, 1024, 868, 816 cm－1; 
HRMS (ESI) calcd for [C13H18ClNO3Na]
＋  (M＋Na＋ ) 
294.0867; found 294.0868. 
3.1.31  N-(4-Bromobutyl)-3,4-dimethoxybenzamide (4x) 
To a solution of 9 (633 mg, 2.50 mmol) in CH2Cl2 (7.5 
mL) at 0 ℃ was added PBr3 (330 mg, 1.20 mmol) and the 
reaction mixture was warmed to room temperature and 
stirred for 24 h. The reaction was quenched with a saturat-
ed aqueous solution of NaHCO3 and extracted with CH2Cl2 
(20 mL×3). The combined organic layers were washed 
with brine, dried over anhydrous Na2SO4, filtered, and 
concentrated under reduced pressure. The residue was pu-
rified by flash chromatography on silica gel [V(EtOAc)∶
V(n-hexane)＝1∶2] to give compound 4x (525 mg, yield 
68%) as a white solid, m.p. 93～94 ℃; 1H NMR (400 
MHz, CDCl3) δ: 1.72～1.82 (m, 2H), 1.88～2.00 (m, 2H), 
3.40～3.52 (m, 4H), 3.90 (s, 3H), 3.91 (s, 3H), 6.40～6.52 
(m, 1H), 6.84 (d, J＝8.4 Hz, 1H), 7.26～7.34 (m, 1H), 
7.40～7.45 (m, 1H); 13C NMR (100 MHz, CDCl3) δ: 28.3, 
30.0, 33.3, 39.1, 56.0 (2C), 110.3, 110.6, 119.2, 127.1, 
149.0, 151.7, 167.2; IR (film) νmax: 3314, 2933, 2842, 
1634, 1547, 1508, 1461, 1337, 1311, 1269, 1231, 1182, 
1131, 1024, 871, 820, 764 cm－1; HRMS (ESI) calcd for 
[C13H18BrNO3Na]
＋ (M＋Na＋) 338.0362; found 338.0367. 
3.1.32  N-(4-Iodobutyl)-3,4-dimethoxybenzamide (4y) 
To a cooled (0 ℃) solution of 9 (633 mg, 2.50 mmol) in 
THF (5.0 mL) was added PPh3 (1.310 g, 5.00 mmol), im-
idazole (375 mg, 5.50 mmol) and I2 (1.265 g, 5.00 mmol) 
sequentially. The reaction mixture was warmed to room 
temperature and stirred for 1 h. The reaction was quenched 
with saturated aqueous Na2S2O3 (2 mL) and the layers were 
separated. The aqueous layer was extracted with EtOAc (20 
mL×3). The combined organic layers were washed with 
brine, dried over anhydrous Na2SO4, filtered, and concen-
trated under reduced pressure. The residue was purified by 
flash chromatography on silica gel [V(EtOAc) ∶
V(n-hexane)＝1∶2] to give compound 4y (720 mg, yield 
79%) as a white solid, m.p. 84～85 ℃; 1H NMR (400 
MHz, CDCl3) δ: 1.68～1.79 (m, 2H), 1.86～1.95 (m, 2H), 
3.22 (t, J＝6.8 Hz, 2H), 3.43～3.50 (m, 2H), 3.91 (s, 3H), 
3.91 (s, 3H), 6.38～6.46 (m, 1H), 6.85 (d, J＝8.4 Hz, 1H), 
7.27～7.34 (m, 1H), 7.40～7.45 (m, 1H); 13C NMR (100 
MHz, CDCl3) δ: 6.31, 30.6, 30.7, 38.9, 55.9 (2C), 110.2, 
110.5, 119.3, 127.1, 148.9, 151.7, 167.2; IR (film) νmax: 
3310, 2922, 2850, 1633, 1580, 1543, 1506, 1460, 1309, 
1268, 1229, 1178, 1131, 1023, 871, 819 cm－1; HRMS 
(ESI) calcd for [C13H18INO3Na]
＋ (M＋Na＋) 386.0224; 
found 386.0219. 
3.1.33  N-(4-Chlorobutyl)acetamide (4z) 
To a solution of acetamide (177 mg, 3.00 mmol) in tol-
uene (12.0 mL) at 0 ℃ was added 4-chloro-butyraldehyde 
(954 mg, 9.00 mmol) followed by triethylsilane (1.40 mL, 
9.00 mmol) and trifluoroacetic acid (0.88 mL, 9.00 mmol) 
and the reaction was heated up to 80 ℃ for 12 h. The 
solvent was evaporated, the residue was dissolved in 
EtOAc and was washed successively with a saturated 
aqueous solution of NaHCO3 and brine, dried over anhy-
drous Na2SO4, filtered, and concentrated under reduced 
pressure. The residue was purified by flash column chro-
matography on silica gel [V(EtOAc)∶V(n-hexane)＝1∶1] 
to give compound 4z (362 mg, yield 81%) as a colorless 
oil. 1H NMR (400 MHz, CDCl3) δ: 1.62～1.73 (m, 2H), 
1.77～1.86 (m, 2H), 1.98 (s, 3H), 3.27 (dd, J＝13.1, 6.8 
Hz, 2H), 3.56 (t, J＝6.5 Hz, 2H), 6.23 (s, 1H); 13C NMR 
(100 MHz, CDCl3) δ: 23.1, 26.8, 29.7, 38.7, 44.5, 170.3; 
IR (film) νmax: 3293, 3085, 2935, 1653, 1554, 1440, 1370, 
1259, 1172, 724 cm － 1; HRMS (ESI) calcd for 
[C6H12ClNONa]
＋ (M＋Na＋) 172.0500; found 172.0509. 
3.1.34  N-Butyl-4-formyl-2-methylbenzamide (4aa) 
To a solution of 4-formyl-2-methylbenzoic acid (492 
mg, 3.00 mmol) and dimethylformamide (50 μL, 0.60 
mmol) in dry toluene (10 mL) at 0 ℃ was added drop-
wise thionylchloride (0.24 mL, 3.30 mmol). The mixture 
was heated to 70 ℃ and stirred for 2 h. The reaction was 
then cooled to 0 ℃ and diluted with CH2Cl2 (15 mL). To 
the resulting mixture were added triethylamine (0.63 mL, 
4.50 mmol) and n-butylamine (219 mg, 3.00 mmol) at 
0 ℃. The reaction mixture was warmed to room tempera-
ture and was stirred for 12 h. The reaction was quenched 
with 2.0 mL of 1.0 mol/L HCl and extracted with CH2Cl2 
(40 mL×4). The combined organic layers were washed 
successively with a saturated aqueous solution of NaHCO3 
and brine, dried over anhydrous Na2SO4, filtered, and con-
centrated under reduced pressure. The residue was purified 
by flash chromatography on silica gel [V(EtOAc) ∶
V(n-hexane)＝1∶2] to give compound 4aa (598 mg, yield 
91%) as a white solid, m.p. 55～56 ℃; 1H NMR (400 
MHz, CDCl3) δ: 0.96 (t, J＝7.3 Hz, 3H), 1.36～1.47 (m, 
2H), 1.55～1.64 (m, 2H), 2.46 (s, 3H), 3.42 (dt, J＝6.6, 6.6 
Hz, 2H), 6.15 (s, 1H), 7.41～7.47 (m, 1H), 7.62～7.70 (m, 
2H), 9.95 (s, 1H); 13C NMR (100 MHz, CDCl3) δ: 13.6, 
19.4, 20.0, 31.6, 39.6, 127.0, 127.2 (2C), 131.8, 136.8, 
142.3, 168.9, 191.7; IR (film) νmax: 3279, 3075, 2960, 
1697, 1643, 1607, 1543, 1465, 1383, 1296, 1228, 1108, 
836, 776, 742, 671 cm － 1; HRMS (ESI) calcd for 
[C13H17NO2Na]
＋(M＋Na＋) 242.1151; found 242.1156. 
3.1.35  4-(3,4-Dimethoxyphenyl)quinolizidin-2-one (8) 
To a solution of 3y (135 mg, 0.330 mmol) in toluene (10 
mL) were sequentially added AIBN (160 mg, 0.980 mmol) 
and (TMS)3SiH (0.50 mL, 1.62 mmol). The resulting mix-
ture was stirred at 75 ℃ for 1.5 h. After being cooled to 
r.t., the solvent was removed under vacuum. The residue 
was purified by flash column chromatography on silica gel 
[V(EtOAc)∶V(n-hexane)∶V(NH3•H2O)＝1∶2∶0.05] to 
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give compound 8[27i] (70 mg, yield 74%) as a colorless oil. 
1H NMR (400 MHz, CDCl3) δ: 1.14～1.25 (m, 1H), 
1.34～1.72 (m, 5H), 2.20 (dt, J＝11.8, 3.3 Hz, 1H), 2.37 
(ddd, J＝15.0, 8.8, 1.3 Hz, 1H), 2.54～2.66 (m, 2H), 
2.84～2.95 (m, 3H), 3.86 (s, 3H), 3.87 (s, 3H), 4.23 (dd,  
J＝6.3, 4.0 Hz, 1H), 6.65～6.72 (m, 2H), 6.78～6.84 (m, 
1H); 13C NMR (100 MHz, CDCl3) δ: 23.4, 24.0, 31.9, 46.8, 
47.5, 51.3, 54.3, 55.8, 55.9, 63.9, 110.7, 111.8, 120.9, 
131.6, 148.4, 148.7, 209.6; IR (film) νmax: 3088, 2926, 
2853, 1713, 1515, 1458, 1259, 1144, 1028, 810        
cm－1; HRMS (ESI) calcd for [C17H23NO3Na]
＋ (M＋Na＋) 
290.1756; found 290.1756. 
3.1.36  (±)-Lasubine I (5) 
To a solution of 8 (30 mg, 0.10 mmol) in THF (3 mL) at 
－78 ℃ was added dropwise a 1.0 mol/L solution of 
L-Selectride in THF (0.12 mL, 0.12 mmol). The mixture 
was stirred at －78 ℃ for 3 h and MeOH (0.15 mL) was 
added. The resulting suspension was treated with a 2.0 
mol/L aqueous solution of NaOH (2.5 mL). The organic 
layer was separated and the aqueous phase was extracted 
with CH2Cl2 (10 mL×3). The combined organic layers 
were washed with brine, dried over anhydrous Na2SO4, 
filtered, and concentrated under reduced pressure. The res-
idue was purified by flash column chromatography on sil-
ica gel [V(EtOAc)∶V(n-hexane)∶V(NH3•H2O) ＝1∶
1∶0.02] to give (±)-lasubine I (5)[27i] (23 mg, yield 77%) 
as a colorless oil. 1H NMR (600 MHz, CDCl3) δ: 1.22～
1.36 (m, 1H), 1.42～1.82 (m, 7H), 1.92～2.20 (m, 3H), 
2.28～2.48 (m, 1H), 2.68～2.82 (m, 1H), 2.90～3.22 (m, 
1H), 3.87 (s, 3H), 3.90 (s, 3H), 4.06～4.30 (m, 2 H), 
6.78～7.10 (m, 3H); 13C NMR (150 MHz, CDCl3) δ: 23.9, 
24.4, 32.2, 40.0 (2C), 51.0, 54.2, 55.8, 56.0, 61.7, 64.9, 
110.7, 111.8, 120.6, 135.1, 148.0, 148.8; IR (film) νmax: 
3354, 2925, 2851, 1513, 1458, 1261, 1143, 1028, 956, 873, 
805 cm－1; HRMS (ESI) calcd for [C17H25NO3Na]
＋ (M＋
Na＋) 292.1907; found 292.1908. 
3.1.37  1-(4-Iodobutyl)-2-methyl-2,3-dihydropyridin- 
4(1H)-one (3ac) 
To a solution of chloride 3z (54 mg, 0.25 mmol) in ace-
tone (5.0 mL) was added NaI (375 mg, 2.50 mmol) and the 
resulting suspension was refluxed for 12 h. The reaction 
was cooled to room temperature, the solvent was evapo-
rated under reduced pressure, and a 1∶1 mixture of 
Et2O/H2O (8.0 mL) was added. The organic layer was sep-
arated and the aqueous phase was extracted with CH2Cl2 
(10 mL×3). The combined organic phase was washed 
with brine, dried over Na2SO4, filtered, and evaporated to 
afford 3ac (71 mg, yield 97%) as a pale yellow oil, which 
was used without further purification in the next reaction 
step. 1H NMR (400 MHz, CDCl3) δ: 1.25 (d, J＝6.7 Hz, 
3H), 1.70～1.80 (m, 2H), 1.82～1.94 (m, 2H), 2.24 (dd, J
＝16.3, 4.2 Hz 1H), 2.74 (dd, J＝16.3, 6.7 Hz, 1H), 3.12～
3.34 (m, 4H), 3.61～3.72 (m, 1H), 4.92 (d, J＝7.4 Hz, 
1H), 6.91 (d, J＝7.4 Hz, 1H); 13C NMR (100 MHz, CDCl3) 
δ: 5.5, 15.2, 30.1 (2C), 42.4, 52.0, 52.3, 97.0, 152.3, 190.5; 
IR (film) νmax: 3052, 2923, 2853, 1574, 1460 cm－
1; HRMS 
(ESI) calcd for [C10H16INONa]
＋ (M＋Na ＋ ) 316.0169; 
found 316.0168. 
3.1.38  (±)-Myrtine hydrochloride salt (6) 
To a solution of 3ac (30 mg, 0.10 mmol) in toluene (3.0 
mL) were sequentially added AIBN (49 mg, 0.30 mmol) 
and (TMS)3SiH (0.16 mL, 0.50 mmol). The resulting mix-
ture was stirred at 75 ℃ for 1.5 h. After cooling to r.t., the 
solvent was removed under vacuum. The residue was puri-
fied by flash column chromatography on silica gel 
[V(EtOAc)∶V(n-hexane)∶V(NH3•H2O)＝1∶2∶0.05] 
and 1.0 mL of 1.0 mol/L HCl was added to give 
(±)-myrtine (6) hydrochloride salt (16 mg, yield 78%) as 
a colorless oil. 1H NMR (400 MHz, CDCl3) δ: 1.30 (d, J＝
5.9 Hz, 3H), 1.38～1.50 (m, 1H), 1.88～2.04 (m, 3H), 
2.26～2.43 (m, 2H), 2.42～2.60 (m, 2H), 2.82～2.96 (m, 
1H), 3.11～3.21 (m, 1H), 3.23～3.34 (m, 1H), 3.40～3.51 
(m, 1H), 3.92～4.10 (m, 2H), 12.85 (s, 1H); 13C NMR 
(150 MHz, CDCl3) δ: 12.7, 21.8, 22.7, 30.6, 45.1, 45.7, 
52.4, 56.6, 58.9, 201.6; IR (film) νmax: 3317, 2922, 2852, 
1733, 1459, 1268, 1100, 770 cm－1; HRMS (ESI) calcd for 
[C10H18NO]
＋ (M－Cl)＋ 168.1383; found 168.1385. 
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